Athira Pharma ATHA
-
-
-
已收盤:-
本益比明細
年季 | 收盤價 | 本業佔比% | 本益比(近四季) | 每股稅後盈餘(元) | 營業利益(千) | 稅後純益(百萬) |
---|---|---|---|---|---|---|
2025Q1 | 0.28 | 104.30 | -0.23 | -9,536 | -9 | |
2024Q4 | 0.59 | 103.75 | -0.39 | -15,566 | -15 | |
2024Q3 | 0.45 | 103.06 | -0.74 | -29,621 | -29 | |
2024Q2 | 2.65 | 104.35 | -0.70 | -28,028 | -27 | |
2024Q1 | 2.74 | 105.13 | -0.69 | -27,687 | -26 | |
2023Q4 | 2.43 | 106.34 | -0.71 | -29,014 | -27 | |
2023Q3 | 2.02 | 106.28 | -0.87 | -35,042 | -33 | |
2023Q2 | 2.95 | 106.90 | -0.78 | -31,640 | -30 | |
2023Q1 | 2.50 | 107.01 | -0.73 | -29,770 | -28 | |
2022Q4 | 3.17 | 109.26 | -0.79 | -32,927 | -30 | |
2022Q3 | 2.97 | 119.54 | -0.54 | -24,133 | -20 | |
2022Q2 | 3.05 | 96.85 | -0.64 | -23,569 | -24 | |
2022Q1 | 13.50 | 111.47 | -0.56 | -23,387 | -21 | |
2021Q4 | 13.03 | 114.93 | -0.44 | -18,778 | -16 | |
2021Q3 | 9.38 | 113.73 | -0.42 | -17,826 | -16 | |
2021Q2 | 10.24 | 119.06 | -0.38 | -16,637 | -14 | |
2021Q1 | 18.40 | 121.60 | -0.25 | -10,781 | -9 | |
2020Q4 | 34.25 | 117.88 | 0.71 | -9,079 | -8 | |
2020Q3 | 18.46 | 87.48 | -1.42 | -7,397 | -8 | |
2020Q2 | -0.07 | -2,252 | -2 |